COVID-19 Vaccine Update: COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days

COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days: Dr. VK Paul, Member-Health, Niti Aayog #COVID19 pic.twitter.com/T0ITsJsixA

— ANI (@ANI) May 18, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)